Mannkind (MNKD) Operating Margin Growth (5y) (2017 - 2026)
Mannkind (MNKD) Operating Margin Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Mannkind | 1.20 Bn | 1.07 Bn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,366.00 |
| Dec 31, 2025 | 12,189.00 |
| Sep 30, 2025 | 8,248.00 |
| Jun 30, 2025 | 396,442.00 |
| Mar 31, 2025 | 7,231.00 |
| Dec 31, 2024 | 10,549.00 |
| Sep 30, 2024 | 127,235.00 |
| Jun 30, 2024 | 549,895.00 |
| Mar 31, 2024 | 10,269.00 |
| Dec 31, 2023 | 6,166.00 |
| Sep 30, 2023 | 49,200.00 |
| Jun 30, 2023 | 53,108.00 |
| Mar 31, 2023 | 75,837.00 |
| Dec 31, 2022 | 60,111.00 |
| Sep 30, 2022 | 135,002.00 |
| Jun 30, 2022 | 135,134.00 |
| Mar 31, 2022 | 47,419.00 |
| Dec 31, 2021 | -9,612.00 |
| Sep 30, 2021 | -10,249.00 |
| Sep 30, 2017 | 10.00 Mn |